Ductal carcinoma in situ: Difference between revisions
Jump to navigation
Jump to search
imported>Robert Badgett (New page) |
mNo edit summary |
||
| (One intermediate revision by one other user not shown) | |||
| Line 1: | Line 1: | ||
{{subpages}} | |||
In [[oncology]], '''ductal carcinoma in situ''' ('''DCIS'''), also called '''noninfiltrating intraductal carcinoma''', is "a noninvasive (noninfiltrating) [[breast cancer|carcinoma of the breast]] characterized by a proliferation of malignant epithelial cells confined to the mammary ducts or lobules, without light-microscopy evidence of invasion through the basement membrane into the surrounding stroma."<ref>{{MeSH}}</ref> | In [[oncology]], '''ductal carcinoma in situ''' ('''DCIS'''), also called '''noninfiltrating intraductal carcinoma''', is "a noninvasive (noninfiltrating) [[breast cancer|carcinoma of the breast]] characterized by a proliferation of malignant epithelial cells confined to the mammary ducts or lobules, without light-microscopy evidence of invasion through the basement membrane into the surrounding stroma."<ref>{{MeSH}}</ref> | ||
| Line 16: | Line 17: | ||
==References== | ==References== | ||
<references/> | <references/>[[Category:Suggestion Bot Tag]] | ||
Latest revision as of 06:00, 9 August 2024
In oncology, ductal carcinoma in situ (DCIS), also called noninfiltrating intraductal carcinoma, is "a noninvasive (noninfiltrating) carcinoma of the breast characterized by a proliferation of malignant epithelial cells confined to the mammary ducts or lobules, without light-microscopy evidence of invasion through the basement membrane into the surrounding stroma."[1]
The importance of DCIS is not clear..[2] However, it may benefit from treatment.[3]
References
- ↑ Anonymous (2024), Ductal carcinoma in situ (English). Medical Subject Headings. U.S. National Library of Medicine.
- ↑ Mandelblatt JS, Cronin KA, Bailey S, Berry DA, de Koning HJ, Draisma G et al. (2009). "Effects of mammography screening under different screening schedules: model estimates of potential benefits and harms.". Ann Intern Med 151 (10): 738-47. DOI:10.1059/0003-4819-151-10-200911170-00010. PMID 19920274. Research Blogging.
- ↑ Cuzick, Jack; Ivana Sestak, Sarah E Pinder, Ian O Ellis, Sharon Forsyth, Nigel J Bundred, John F Forbes, Hugh Bishop, Ian S Fentiman, William D George (2010). "Effect of tamoxifen and radiotherapy in women with locally excised ductal carcinoma in situ: long-term results from the UK/ANZ DCIS trial". The Lancet Oncology. DOI:10.1016/S1470-2045(10)70266-7. ISSN 14702045. Retrieved on 2010-12-08. Research Blogging.